- Trials with a EudraCT protocol (341)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (71)
341 result(s) found for: Mucosa.
Displaying page 1 of 18.
EudraCT Number: 2012-001768-31 | Sponsor Protocol Number: ZENO-01 | Start Date*: 2012-09-03 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: ZENO-01 90Y ibritumomab tiuxetan in patients with extra-nodal marginal zone B-cell lymphoma of Mucosa associated lymphoid tissue (MALT Lymphoma) | |||||||||||||
Medical condition: MALT Lymphoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004289-42 | Sponsor Protocol Number: ZENO-06021957 | Start Date*: 2008-03-20 | |||||||||||
Sponsor Name:National and Kapodistrian University of Athens | |||||||||||||
Full Title: 90Y ibritumomab tiuxetan (Zevalin®) in patients with extra-nodal marginal zone B-cell lymphoma of Mucosa associated lymphoid tissue (MALT Lymphoma) | |||||||||||||
Medical condition: extra-nodal marginal zone B-cell lymphoma of Mucosa associated lymphoid tissue (MALT Lymphoma) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-000767-41 | Sponsor Protocol Number: AGMT_MALT | Start Date*: 2008-04-30 | |||||||||||
Sponsor Name:Arbeitsgemeinschaft medikamentöse Tumortherapie gemeinnützige GmbH | |||||||||||||
Full Title: Phase II Trial of Rituximab Plus 2CdA in Patients with Advanced or Relapsed Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT) | |||||||||||||
Medical condition: Lymphoma of the Mucosa-Associated Lymphoid Tissue (MALT) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005818-10 | Sponsor Protocol Number: AGMT_MALT-2 | Start Date*: 2012-05-02 | |||||||||||
Sponsor Name:Arbeitsgemeinschaft medikamentöse Tumortherapie gemeinnützige GmbH | |||||||||||||
Full Title: PHASE II TRIAL OF RITUXIMAB (MABTHERA®) PLUS LENALIDOMIDE (REVLIMID®) IN PATIENTS WITH LYMPHOMA OF THE MUCOSA ASSOCIATED LYMPHOID TISSUE (MALT) | |||||||||||||
Medical condition: Lymphoma of the Mucosa-Associated Lymphoid Tissue (MALT) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004896-38 | Sponsor Protocol Number: IELSG38 | Start Date*: 2014-02-13 | |||||||||||
Sponsor Name:IELSG (International Extranodal Lymphoma Study Group) | |||||||||||||
Full Title: A PHASE II STUDY OF CHLORAMBUCIL IN COMBINATION WITH SUBCUTANEOUS RITUXIMAB FOLLOWED BY MAINTENANCE THERAPY WITH SUBCUTANEOUS RITUXIMAB IN PATIENTS WITH EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA OF ... | |||||||||||||
Medical condition: Patients with MALT Lymphoma treated with chlorambucil and rituximab followed by maintenance treatment with subcutaneous rituximab | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Trial now transitioned) FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-007725-39 | Sponsor Protocol Number: MALT2008-01 | Start Date*: 2009-05-05 | |||||||||||
Sponsor Name:Fundación GEL/TAMO | |||||||||||||
Full Title: ESTUDIO MULTICENTRICO FASE II, NO ALEATORIZADO, DE RITUXIMAB EN COMBINACIÓN CON BENDAMUSTINA COMO PRIMER TRATAMIENTO SISTÉMICO EN LINFOMA DE CÉLULAS B DE LA ZONA MARGINAL EXTRAGANGLIONAR DEL TEJID... | |||||||||||||
Medical condition: Linfoma no hodgkiniano marginal de tipo MALT en una primera línea de inmunoquimioterapia. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003215-63 | Sponsor Protocol Number: 69HCL19_0032 | Start Date*: 2020-03-10 | |||||||||||
Sponsor Name:Hospices Civils de Lyon - Direction de la Recherche Clinique et de l'Innovation | |||||||||||||
Full Title: Cultured Autologous Oral Mucosa Epithelial sheet for the Treatment of Bilateral Limbal Stem Cell Deficiency - FEMJA for « Feuillet Epithélial de Muqueuse Jugale Autologue » | |||||||||||||
Medical condition: Bilateral Limbal Stem Cell Deficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000791-29 | Sponsor Protocol Number: CICLO-LPO | Start Date*: 2017-07-13 | |||||||||||
Sponsor Name:Clínica Universidad de Navarra/Universidad de Navarra | |||||||||||||
Full Title: Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of cyclosporine mucoadhesive gel at two different concentrations in the topical treatment of lichen planus in ... | |||||||||||||
Medical condition: oral lichen planus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004419-11 | Sponsor Protocol Number: SC35 | Start Date*: 2017-04-20 | ||||||||||||||||
Sponsor Name:Radboud university medical center | ||||||||||||||||||
Full Title: Safety and efficacy of interleukin-1 inhibitor anakinra for the amelioration of fever during neutropenia and mucositis in patients with multiple myeloma receiving an autologous hematopoietic stem c... | ||||||||||||||||||
Medical condition: Mucositis and febrile neutropenia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-003031-70 | Sponsor Protocol Number: N-ART-06-112 | Start Date*: 2006-11-29 | |||||||||||
Sponsor Name:LABORATORIOS NORMON S.A. | |||||||||||||
Full Title: Evaluación de la profundidad anestésica de la lidocaína 1:100.000 frente a la articaína 1:100.000, en la cirugía del tercer molar inferior. Estudio comparativo | |||||||||||||
Medical condition: Estudio paralelo de eficacia anestésica con las combinaciones de articaína y lidocaína con epinefrina en la extracción del tercer molar inferior en pacientes con tercer molar inferior retenido. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-014833-26 | Sponsor Protocol Number: IEO S500/409 | Start Date*: 2010-07-29 | |||||||||||
Sponsor Name:ISTITUTO EUROPEO DI ONCOLOGIA | |||||||||||||
Full Title: Phase IIB Randomized, Placebo Controlled Trial of Pioglitazone for Oral Premalignant Lesions. An Inter-Consortium Collaborative Study. | |||||||||||||
Medical condition: oral premalignant lesions | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005634-12 | Sponsor Protocol Number: EPA/POL/02 | Start Date*: 2006-06-12 |
Sponsor Name:S.L.A. Pharma (UK) Ltd | ||
Full Title: The effect of two dose levels of eicosapentaenoic acid (EPA) on apoptosis and cell proliferation in the colonic mucosa of patients with a history of colonic polyps. | ||
Medical condition: Sporadic colonic adenomata | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) IT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-003486-17 | Sponsor Protocol Number: 9-VPH-MVIH | Start Date*: 2020-02-11 |
Sponsor Name:CARMEN HIDALGO TENORIO | ||
Full Title: Immunogenicity and safety of a 9-valent human papillomavirus vaccine in HIV-positive women | ||
Medical condition: New infection and lesions of papillomavirus in HIV-infected women | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-000063-28 | Sponsor Protocol Number: GAA 5232 | Start Date*: 2006-05-09 |
Sponsor Name:BODE Chemie GmbH | ||
Full Title: A monocentric, double-blind, randomized phase III clinical study to investigate the antimicrobial efficacy and local tolerability of an antiseptic (Stellisept mucosa, containing 0.1 % octenidine di... | ||
Medical condition: antisepsis of genital mucous membranes | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-006196-19 | Sponsor Protocol Number: OC003SB | Start Date*: 2012-02-28 |
Sponsor Name:Clinical Research Centre, Hvidovre University Hospital | ||
Full Title: Clinical Trials with lozenge as local anaesthesia as treatment of oral pain in burning mouth syndrome and Sjögrens syndrome | ||
Medical condition: Oral pain caused by the illnesses burning mouth syndrome, Sjögren's syndrome and lichen planus | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2016-001193-15 | Sponsor Protocol Number: FASTERCC-001 | Start Date*: 2016-07-06 | |||||||||||||||||||||||||||||||
Sponsor Name:Department of Oncology, Aarhus University Hospital | |||||||||||||||||||||||||||||||||
Full Title: Folic acid supplement versus placebo for treating mucositis adverse events in metastatic renal cell carcinoma patients receiving targeted therapy (FASTERCC). A randomized, double-blind, phase II ... | |||||||||||||||||||||||||||||||||
Medical condition: Mucositis (nasal, oral, pharyngeal, anal, or genital) is often experienced in relation to TKI and mTOR inhibitor treatment of metastatic renal cell carcinoma patients. The present trial will assess... | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000061-11 | Sponsor Protocol Number: GAA 5233 | Start Date*: 2006-04-03 |
Sponsor Name:BODE Chemie GmbH & Co | ||
Full Title: Prospective randomized controlled double-blind multicentric phase III study to evaluate antiseptic efficacy and local tolerability of Stellisept mucosa in patients with chronic wounds | ||
Medical condition: ulcus cruris | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-000980-93 | Sponsor Protocol Number: I-ICRNS-003-VLPNX-01 | Start Date*: 2005-05-12 | |||||||||||
Sponsor Name:CRINOS S.P.A. | |||||||||||||
Full Title: A randomised, double blind, multicentre Italian study, to assess the efficacy and tolerability of octatropine methilbromide in combination with diazepam(Valpinax) compared versus placebo in the tre... | |||||||||||||
Medical condition: vascular disease at thrombotic risk | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000522-22 | Sponsor Protocol Number: ISO-CC-002 | Start Date*: 2012-05-30 | |||||||||||
Sponsor Name:Isofol Medical AB | |||||||||||||
Full Title: A Single-blind, Randomized Phase I/II study of Pharmacokinetic and Pharmacodynamic investigation of Modufolin® (60 or 200 mg/m2) compared to Levoleucovorin (60 or 200 mg/m2) in tumour, adjacent muc... | |||||||||||||
Medical condition: Colon cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-003532-71 | Sponsor Protocol Number: MC/Ph.III-2019 | Start Date*: 2019-10-29 | |||||||||||
Sponsor Name:MukoCell GmbH | |||||||||||||
Full Title: Efficacy and safety of a tissue-engineered oral mucosa (MukoCell®) vs. native oral mucosa graft urethroplasty in male patients with urethral stricture | |||||||||||||
Medical condition: Urethral stricture | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
